The Green Bay Packers, Bellin Well being, and the Vince Lombardi Cancer Foundation have partnered for the seventh consecutive year to launch the Packers Vs. Cancer campaign. This initiative aims to raise awareness about all kinds of cancers, produce funds for analysis and care, and emphasize the significance of early screenings in saving lives.
Packers President/CEO Mark Murphy expressed his pleasure in continuing the Packers Vs. Cancer work and displaying assistance for cancer sufferers and their loved ones. He acknowledged the important influence the campaign has had in the previous six years and highlighted the collaboration with Bellin Well being and the Vince Lombardi Cancer Foundation. The Packers organization is committed to contributing to cancer analysis funding and reminding fans to prioritize screenings.
To kick off the campaign, Packers cornerback Keisean Nixon and operating back Patrick Taylor joined representatives from Bellin Well being and the Vince Lombardi Cancer Foundation at the Bellin Well being Cancer Group. Nixon, this year’s campaign spokesperson, shared his family’s encounter with cancer, adding a individual touch to the announcement.
Subsequently, the group received a tour of the Bellin Well being Cancer Group facility, which provides a variety of cancer therapy and assistance solutions such as health-related and radiation oncology, infusion solutions, oncology genetics, and physical and speech therapy. Bellin Well being annually administers about 15,000 infusions and ten,000 total radiation therapies.
As portion of this year’s Packers Vs. Cancer campaign, a new Packers Vs. Cancer hat has been introduced. Every sale of this hat will contribute $five straight to the Vince Lombardi Cancer Foundation. The hat, a green New Era winter knit with the Packers logo on the front and the Packers Vs. Cancer logo on the side, is at present offered for acquire each in-shop and on the net. Moreover, shoppers at the Packers Pro Shop have the chance to donate $1 or additional to the Vince Lombardi Cancer Foundation in the course of their acquire till October 16, producing assistance for ongoing cancer analysis applications.